Intrinsic Value of S&P & Nasdaq Contact Us

Genmab A/S GMAB NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • DK • USD

SharesGrow Score
76/100
5/7 Pass
SharesGrow Intrinsic Value
$10.40
-64.2%
Analyst Price Target
$42.13
+45%

Genmab A/S (GMAB) has 12 identified peers for comparison in the Healthcare sector. Peers include AKRO, ALEC, AMLX, APLS, ASND, BGNE and others.

GMAB has a market capitalization of $17.94B, compared to an average peer market cap of $6.4B. GMAB is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message